According to a new report published by UnivDatos Markets Insights, the Glioblastoma Multiforme Treatment (GBM) market was valued at USD 2 billion in 2021 is expected to grow at a CAGR of 8% from 2022-2030. The analysis has been segmented into Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, and Immunotherapy); End-Use (Hospitals, Clinics, Ambulatory Surgical Centers, and Others); Region/Country.
Get the inside scoop with Sample report @ https://univdatos.com/report/glioblastoma-multiforme-treatment-gbm-market/get-a-free-sample-form.php?product_id=38265
The glioblastoma multiforme treatment (GBM) market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the glioblastoma multiforme treatment (GBM) market. The glioblastoma multiforme treatment (GBM) market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the glioblastoma multiforme treatment (GBM) market at the global and regional levels.
Key Market Dynamics
Glioblastoma multiforme is a common type of brain tumor and is an extremely dangerous form of cancer. The survival rate of this disorder is extreme which is an important factor in the high need for on-time glioblastoma multiforme treatment. For instance, as per the Brain Tumour Charity Organization, the average survival time for glioblastoma is 12-18 months. Only 25% of patients survive 1 year or more, and only 5% of patients survive 5 years or more. Further, due to the high mortality rate of the disease, governmental and private organizations are putting efforts into finding the appropriate treatment for the disease.
FIG. 1 Global Glioblastoma Multiforme Treatment (GBM) Market Revenue, by Region 2021 (% Share) |
|
Source: UnivDatos Market Insights
The COVID-19 pandemic has had a significant impact on the healthcare industry, including the market for glioblastoma multiforme (GBM) treatment. GBM is a highly aggressive type of brain cancer that requires prompt and effective treatment. However, the pandemic has disrupted the delivery of healthcare services and affected the demand for GBM treatments. Further, delayed diagnosis also leads to a more advanced stage of the disease and may limit treatment options. Hence, the market for GBM treatment witnessed a negative impact due to COVID-19.
Based on treatment, the market is segmented into surgery, radiation therapy, chemotherapy, targeted therapy, tumor treating Field (TTF) therapy, and immunotherapy. The radiation therapy segment acquired a major share in 2021.
Based on the end-use, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The clinics segment is expected to grow with the highest CAGR during the forecast period.
Ask for Report Customization @ https://univdatos.com/report/glioblastoma-multiforme-treatment-gbm-market/get-a-free-sample-form.php?product_id=38265
Glioblastoma Multiforme Treatment (GBM) Market Geographical Segmentation Includes:
North America (U.S., Canada, and the Rest of North America)
Europe (Germany, UK, Spain, Italy, France, Rest of Europe)
Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific)
Rest of the World
The Asia Pacific is expected to grow with the highest CAGR glioblastoma multiforme treatment (GBM) market during the forecast period. This is mainly due to the presence of large and rapidly aging populations, and increasing incidence of brain tumors, including GBM. For instance, as per the Asian Development Bank, by 2050, one in four people in the Asia-Pacific region will be over the age of 60. The region's elderly (over 60) population will triple between 2010 and 2050, reaching nearly 1.3 billion.
The major players targeting the Global Glioblastoma Multiforme Treatment (GBM) market:
Company Name | Company Logo | Revenue (2021) |
Merck Co., Inc. |
| USD 29 Mn |
Amgen Inc. |
| USD 62.4 Mn |
Bristol-Myers Squibb Company |
| USD XX Mn |
Pfizer Inc. |
| USD XX Mn |
Teva Pharmaceutical Industries Ltd. |
| USD XX Mn |
Sun Pharmaceutical Industries Ltd. |
| USD XX Mn |
Amneal Pharmaceuticals LLC |
| USD XX Mn |
Karyopharm |
| USD XX Mn |
F. Hoffmann-La Roche Ltd |
| USD XX Mn |
Sumitomo Pharma Oncology, Inc |
| USD XX Mn |
Competitive Landscape
The degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the Glioblastoma Multiforme Treatment (GBM) market. The major players have been analyzed by using research methodologies such as Porters Five Forces Analysis for getting insight views on global competition.
Check complete Table of Contents with List of Table and Figures @ https://univdatos.com/report/glioblastoma-multiforme-treatment-gbm-market/
Recent Developments:
In 2022, the FDA approved the two-drug combination dabrafenib and trametinib. These agents fall into the category of targeted therapies that attack cancer cells harboring BRAF mutations.
In 2020, Cadila Pharmaceuticals launched cancer named Bavaro in India. The drug is used to treat multiple cancers including glioblastoma multiforme.
Key questions resolved through this analytical market research report include:
What are the latest trends, new patterns, and technological advancements in the glioblastoma multiforme treatment (GBM) market?
Which factors are influencing the glioblastoma multiforme treatment (GBM) market over the forecast period?
What are the global challenges, threats, and risks of the glioblastoma multiforme treatment (GBM) market?
Which factors are propelling and restraining the glioblastoma multiforme treatment (GBM) market?
What are the demanding global regions of the glioblastoma multiforme treatment (GBM) market?
What will be the global market size in the upcoming years?
What are the crucial market acquisition strategies and policies applied by global companies?
What are the descriptive profiles of key companies along with their SWOT analysis?
We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature and geography. Please let us know If you have any custom needs.
About UnivDatos Market Insights (UMI)
Browse Other Related Research Reports from UnivDatos Market Insights
Liquid Biopsy in Cancer Diagnostic Market
Cancer Registry Software Market
Neoantigen Cancer Vaccine Market
Multi Cancer Early Detection Market
Glioblastoma Multiforme Treatment (GBM) Market Report Coverage
